Developing patient-specific adverse effect profiles: the next frontier for precision medicine in dermatology
Main Authors: | Derek Nie, Kyle Tegtmeyer, Jeffrey Zhao, Peter A Lio |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-04-01
|
Series: | Journal of Dermatological Treatment |
Online Access: | http://dx.doi.org/10.1080/09546634.2019.1687810 |
Similar Items
-
Off-Label studies on anakinra in dermatology: a review
by: Kyle Tegtmeyer, et al.
Published: (2022-01-01) -
Off-label studies on tofacitinib in dermatology: a review
by: Kyle Tegtmeyer, et al.
Published: (2021-05-01) -
The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine
by: Bruno Fuchs, et al.
Published: (2023-10-01) -
Off-label studies on apremilast in dermatology: a review
by: Nolan J. Maloney, et al.
Published: (2020-02-01) -
Pharmacogenomics/updated for precision medicine in dermatology
by: Le Hanh Dung Do, et al.
Published: (2019-05-01)